<?xml version="1.0" encoding="UTF-8"?>
<p>According to the European Renal Associationâ€”European Dialysis and Transplant Association (ERA-EDTA) guidelines (
 <xref rid="B74" ref-type="bibr">74</xref>), in patients with COVID-19 and without pneumonia, complete withdrawal of immunosuppressants -particularly calcineurin inhibitors (CNI)- is discouraged. Reduction of the dosage of CNI, and withdrawal of mycophenolate, azathioprine, or mTOR-inhibitors should be individualized considering the severity of the disease (
 <xref rid="B74" ref-type="bibr">74</xref>). The concurrent use of antivirals and anti-inflammatories should be carefully considered with attention to drug-drug interactions that may affect the half-life of immunosuppressant drugs (
 <xref rid="B74" ref-type="bibr">74</xref>).
</p>
